• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer

    RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer

  2. CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results

    CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results

  3. Merus Labs Appoints New Director and Provides European Update

    Merus Labs Appoints New Director and Provides European Update

  4. S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

    S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

  5. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

  6. Investors Scoop Up Companies' Bonds

    Investors Scoop Up Companies' Bonds

  7. Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery

    Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery

  8. UPDATE: These are the top-performing S&P 500 stocks of 2015

    UPDATE: These are the top-performing S&P 500 stocks of 2015

  9. UPDATE: These are the top-performing S&P 500 stocks of 2015

    UPDATE: These are the top-performing S&P 500 stocks of 2015

  10. UPDATE: These are the top-performing S&P 500 stocks of 2015

    UPDATE: These are the top-performing S&P 500 stocks of 2015

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.